Direct sequencing analysis of transmembrane region of human neu gene by polymerase chain reaction

Hideyuki Saya, S. Ara, P. S Y Lee, J. Ro, M. C. Hung

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The neu gene in rat neuro/glioblastoma was found to be activated by a single point mutation in the DNA sequence encoding the transmembrane region of the neu-encoded p185 protein. The human homologue of the rat neu gene, termed c-erbB-2 or HER-2, can also be activated in vitro by a similar mutation in the corresponding region. Although the human neu gene was shown to be amplified/overexpressed in a large portion of human breast and ovarian cancer, no reports indicate that the human neu gene is activated by a point mutation in human tumor. To study the possible point mutation of neu gene in human tumors, we characterized the genomic structure in the transmembrane region of human neu gene, which in turn allowed us to determine DNA sequence in this region directly following DNA amplification by polymerase chain reaction. We analyzed 7 tumor cell lines (2 breast cancer, 1 neuroblastoma, 1 rhabdomyosarcoma, and 3 glioma) and 11 tumor tissue samples (8 breast and 3 ovarian cancers). No mutation was found in the transmembrane region of human neu gene. Our results suggest that unlike the rat neuro/glioblastoma, the single point mutation in the transmembrane region of the human neu gene is a rare event in human tumors. In this study, we developed a technique for direct DNA sequencing of the transmembrane region of the human neu gene. This technique makes it possible to screen a large number of tumor samples.

Original languageEnglish
Pages (from-to)198-201
Number of pages4
JournalMolecular Carcinogenesis
Volume3
Issue number4
Publication statusPublished - 1990
Externally publishedYes

Fingerprint

erbB-2 Genes
Polymerase Chain Reaction
Point Mutation
Neoplasms
Glioblastoma
Ovarian Neoplasms
Breast Neoplasms
Mutation
DNA-Directed DNA Polymerase
Tumor Cell Line
Neuroblastoma
DNA Sequence Analysis
Glioma
Breast

Keywords

  • activating mutation
  • direct DNA sequencing
  • neu gene
  • polymerase chain reaction

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology

Cite this

Direct sequencing analysis of transmembrane region of human neu gene by polymerase chain reaction. / Saya, Hideyuki; Ara, S.; Lee, P. S Y; Ro, J.; Hung, M. C.

In: Molecular Carcinogenesis, Vol. 3, No. 4, 1990, p. 198-201.

Research output: Contribution to journalArticle

Saya, Hideyuki ; Ara, S. ; Lee, P. S Y ; Ro, J. ; Hung, M. C. / Direct sequencing analysis of transmembrane region of human neu gene by polymerase chain reaction. In: Molecular Carcinogenesis. 1990 ; Vol. 3, No. 4. pp. 198-201.
@article{702c64e197124932bd98adae62251d69,
title = "Direct sequencing analysis of transmembrane region of human neu gene by polymerase chain reaction",
abstract = "The neu gene in rat neuro/glioblastoma was found to be activated by a single point mutation in the DNA sequence encoding the transmembrane region of the neu-encoded p185 protein. The human homologue of the rat neu gene, termed c-erbB-2 or HER-2, can also be activated in vitro by a similar mutation in the corresponding region. Although the human neu gene was shown to be amplified/overexpressed in a large portion of human breast and ovarian cancer, no reports indicate that the human neu gene is activated by a point mutation in human tumor. To study the possible point mutation of neu gene in human tumors, we characterized the genomic structure in the transmembrane region of human neu gene, which in turn allowed us to determine DNA sequence in this region directly following DNA amplification by polymerase chain reaction. We analyzed 7 tumor cell lines (2 breast cancer, 1 neuroblastoma, 1 rhabdomyosarcoma, and 3 glioma) and 11 tumor tissue samples (8 breast and 3 ovarian cancers). No mutation was found in the transmembrane region of human neu gene. Our results suggest that unlike the rat neuro/glioblastoma, the single point mutation in the transmembrane region of the human neu gene is a rare event in human tumors. In this study, we developed a technique for direct DNA sequencing of the transmembrane region of the human neu gene. This technique makes it possible to screen a large number of tumor samples.",
keywords = "activating mutation, direct DNA sequencing, neu gene, polymerase chain reaction",
author = "Hideyuki Saya and S. Ara and Lee, {P. S Y} and J. Ro and Hung, {M. C.}",
year = "1990",
language = "English",
volume = "3",
pages = "198--201",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Direct sequencing analysis of transmembrane region of human neu gene by polymerase chain reaction

AU - Saya, Hideyuki

AU - Ara, S.

AU - Lee, P. S Y

AU - Ro, J.

AU - Hung, M. C.

PY - 1990

Y1 - 1990

N2 - The neu gene in rat neuro/glioblastoma was found to be activated by a single point mutation in the DNA sequence encoding the transmembrane region of the neu-encoded p185 protein. The human homologue of the rat neu gene, termed c-erbB-2 or HER-2, can also be activated in vitro by a similar mutation in the corresponding region. Although the human neu gene was shown to be amplified/overexpressed in a large portion of human breast and ovarian cancer, no reports indicate that the human neu gene is activated by a point mutation in human tumor. To study the possible point mutation of neu gene in human tumors, we characterized the genomic structure in the transmembrane region of human neu gene, which in turn allowed us to determine DNA sequence in this region directly following DNA amplification by polymerase chain reaction. We analyzed 7 tumor cell lines (2 breast cancer, 1 neuroblastoma, 1 rhabdomyosarcoma, and 3 glioma) and 11 tumor tissue samples (8 breast and 3 ovarian cancers). No mutation was found in the transmembrane region of human neu gene. Our results suggest that unlike the rat neuro/glioblastoma, the single point mutation in the transmembrane region of the human neu gene is a rare event in human tumors. In this study, we developed a technique for direct DNA sequencing of the transmembrane region of the human neu gene. This technique makes it possible to screen a large number of tumor samples.

AB - The neu gene in rat neuro/glioblastoma was found to be activated by a single point mutation in the DNA sequence encoding the transmembrane region of the neu-encoded p185 protein. The human homologue of the rat neu gene, termed c-erbB-2 or HER-2, can also be activated in vitro by a similar mutation in the corresponding region. Although the human neu gene was shown to be amplified/overexpressed in a large portion of human breast and ovarian cancer, no reports indicate that the human neu gene is activated by a point mutation in human tumor. To study the possible point mutation of neu gene in human tumors, we characterized the genomic structure in the transmembrane region of human neu gene, which in turn allowed us to determine DNA sequence in this region directly following DNA amplification by polymerase chain reaction. We analyzed 7 tumor cell lines (2 breast cancer, 1 neuroblastoma, 1 rhabdomyosarcoma, and 3 glioma) and 11 tumor tissue samples (8 breast and 3 ovarian cancers). No mutation was found in the transmembrane region of human neu gene. Our results suggest that unlike the rat neuro/glioblastoma, the single point mutation in the transmembrane region of the human neu gene is a rare event in human tumors. In this study, we developed a technique for direct DNA sequencing of the transmembrane region of the human neu gene. This technique makes it possible to screen a large number of tumor samples.

KW - activating mutation

KW - direct DNA sequencing

KW - neu gene

KW - polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=0025167538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025167538&partnerID=8YFLogxK

M3 - Article

C2 - 2206283

AN - SCOPUS:0025167538

VL - 3

SP - 198

EP - 201

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 4

ER -